Posts By: Alnylam Pharmaceuticals
March 29, 2019
Team Alnylam Hits the Court to Support Massachusetts Special Olympics Alnylam joined more than a dozen biotech companies in the annual Bioball Basketball Tournament to support the Massachusetts Special Olympics.
Read More ›
August 3, 2018
Barry Greene Named to PharmaVoice 100 "For Being an RNAi Champion" Alnylam President Barry Greene has been named to the PharmaVoice 100 for 2018. Barry was selected "for being an RNAi champion."
Read More ›
May 9, 2018
First Rounders: John Maraganore Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech.
Read More ›
December 11, 2018
John Maraganore Named to Bloomberg 50 List for 2018 Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018.
Read More ›
November 8, 2018
Celebrating Alnylam's 1000th Employee! We were founded 16 years ago on the belief that we could translate the Nobel Prize-winning discovery of RNA interference (#RNAi) into an entirely new class...
Read More ›
May 12, 2019
Ania (UK) - Living with Acute Intermittent Porphyria (AIP) Ania from the UK is living with acute intermittent porphyria (AIP), a type of acute hepatic porphyria (AHP). In this video, she shares her story and thoughts...
Read More ›
February 20, 2019
Alnylam Named a Fast Company World's Most Innovative Company for 2019 Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019.
Read More ›
June 24, 2019
Alnylam Honored by NORD with a Rare Impact Award Alnylam Honored by NORD with a Rare Impact Award for the development and approval of ONPATTRO (patisiran).
Read More ›
June 10, 2019
Alnylam Named a Best Workplace in Switzerland & UK Alnylam's offices in Maidenhead, UK and Zug, Switzerland were both recently named to Great Place to Work's Best Workplaces for 2019.
Read More ›
November 16, 2018
Alnylam Named a Boston Globe Top Place to Work for the 4th Year in a Row Alnylam has been named to the Boston Globe's list of Top Places to Work for 2018 marking our fourth year in a row on the list. We are ranked #18 out of the...
Read More ›
August 3, 2018
Barry Greene Named to PharmaVoice 100 "For Being an RNAi Champion"
Alnylam President Barry Greene has been named to the PharmaVoice 100 for 2018. Barry was selected "for being an RNAi champion."
Read More ›
May 9, 2018
First Rounders: John Maraganore
Our CEO John Maraganore, Ph.D. recently chatted with the Nature Biotechnology Podcast about his path into science, through research and ultimately into biotech.
Read More ›
December 11, 2018
John Maraganore Named to Bloomberg 50 List for 2018
Alnylam CEO John Maraganore has been named to the Bloomberg 50 list for 2018.
Read More ›
November 8, 2018
Celebrating Alnylam's 1000th Employee!
We were founded 16 years ago on the belief that we could translate the Nobel Prize-winning discovery of RNA interference (#RNAi) into an entirely new class...
Read More ›
May 12, 2019
Ania (UK) - Living with Acute Intermittent Porphyria (AIP)
Ania from the UK is living with acute intermittent porphyria (AIP), a type of acute hepatic porphyria (AHP). In this video, she shares her story and thoughts...
Read More ›
February 20, 2019
Alnylam Named a Fast Company World's Most Innovative Company for 2019
Alnylam has been named #3 in Biotech on Fast Company's World's 50 Most Innovative Company for 2019.
Read More ›
June 24, 2019
Alnylam Honored by NORD with a Rare Impact Award
Alnylam Honored by NORD with a Rare Impact Award for the development and approval of ONPATTRO (patisiran).
Read More ›
June 10, 2019
Alnylam Named a Best Workplace in Switzerland & UK
Alnylam's offices in Maidenhead, UK and Zug, Switzerland were both recently named to Great Place to Work's Best Workplaces for 2019.
Read More ›
November 16, 2018
Alnylam Named a Boston Globe Top Place to Work for the 4th Year in a Row
Alnylam has been named to the Boston Globe's list of Top Places to Work for 2018 marking our fourth year in a row on the list. We are ranked #18 out of the...
Read More ›
